Feline Rabies

Feline rabies is a fatal viral encephalitis of domestic cats caused by the rabies virus (RABV), a neurotropic RNA virus belonging to the genus Lyssavirus within the family Rhabdoviridae. Although cats are not considered a true reservoir species for RABV, they serve as important incidental hosts and vectors, acquiring infection from wildlife reservoirs (bats, raccoons, foxes, and others) or unvaccinated dogs in regions where canine rabies remains endemic [3]. The disease is of profound public health significance because cats are increasingly implicated in human rabies exposures globally, including documented fatal human cases in South America, Asia, and North America [1][6]. Once clinical signs appear, rabies is virtually 100% fatal in cats, making prevention through vaccination the cornerstone of disease control [3].

Causative Agent: Rabies virus (RABV) is a negative-sense, single-stranded RNA virus in the genus Lyssavirus. Multiple antigenic variants (biotypes) circulate globally; cats become infected with whatever variant predominates in local wildlife reservoirs [1][3]. In Brazil, for example, AgV3 (bat-associated) has been the predominant variant identified in cat-related human rabies cases, followed by AgV2 (dog-associated) [1]. In Colombia, domestic cats have become a leading species in human rabies transmission in Andean regions, reflecting spillover from both dog and wildlife cycles [6]. In New York State, cats are consistently the most commonly confirmed rabid domestic animal, with infections variant-typed to raccoon and bat lineages [4].

Transmission: Cats acquire infection primarily through bites from infected animals; less commonly via scratch or mucous membrane contact with infected saliva. Virus shed in saliva can be present for a few days prior to clinical signs, creating a window for transmission before the animal is recognizably ill [3]. Because cats are outdoor-ranging predators that frequently hunt bats and small wildlife, they have disproportionately high exposure risk compared to dogs [3][4].

Pathogenesis:

1. ·Local replication and centripetal neural spread: After inoculation, RABV replicates locally in muscle and non-neural tissues near the wound, then binds nicotinic acetylcholine receptors (and other neuronal receptors including NCAM, p75NTR) at neuromuscular junctions and enters peripheral nerve axons via receptor-mediated endocytosis.
2. ·Retrograde axonal transport: The virus travels in a retrograde direction (estimated 50–100 mm/day in peripheral nerves) toward the dorsal root ganglia and spinal cord. The incubation period (typically 2 weeks to several months) reflects the distance from the bite site to the central nervous system (CNS).
3. ·CNS dissemination: Once in the spinal cord and brain, RABV spreads rapidly through the entire CNS, causing encephalitis characterized by neuronal degeneration, perivascular cuffing, and non-suppurative inflammation. Pathognomonic Negri bodies — intracytoplasmic eosinophilic inclusion bodies composed of viral nucleocapsids — are found in neurons, classically in cerebellar Purkinje cells and hippocampal pyramidal neurons.
4. ·Centrifugal spread: Virus spreads outward from the CNS via autonomic and sensory nerves to peripheral tissues including salivary glands (enabling transmission), cornea, skin, and other organs.
5. ·Clinical disease: Neurological dysfunction arises from disruption of neurotransmission, excitotoxic neuronal injury, and inflammatory damage rather than massive neuronal death alone. The virus actively suppresses innate immune responses, allowing nearly unchecked replication within the immune-privileged CNS [3].

Risk factors in cats:

• ·Outdoor or free-roaming lifestyle
• ·Lack of rabies vaccination
• ·Geographic location (endemic wildlife rabies zones)
• ·Contact with bats, raccoons, foxes, skunks, or unvaccinated dogs [4][3]

Ante-mortem diagnosis: Definitive ante-mortem diagnosis of rabies in a live, clinically ill cat is exceptionally difficult and not reliably achievable with routine testing. Rabies must be considered in any cat presenting with unexplained acute progressive neurological signs, especially with a history of wildlife exposure or bite wounds [3][4].

Ante-mortem tests (limited sensitivity/specificity in clinical practice):

• ·Direct fluorescent antibody (DFA) test on skin biopsy (nape of neck, hair follicle-rich skin) — detects viral antigen in cutaneous nerve fibers; sensitivity is imperfect, and a negative result does not exclude rabies
• ·RT-PCR on saliva, cerebrospinal fluid, or skin biopsy — molecular confirmation possible but not widely available in real-time clinical settings
• ·Serology (virus neutralization or RFFIT) — detects antibody response but unreliable in unvaccinated animals with rapid disease progression; primarily used to confirm vaccine response
• ·Cerebrospinal fluid analysis — may show mild non-specific mononuclear pleocytosis; findings are not pathognomonic

Post-mortem diagnosis (definitive — required for public health investigation):

• ·Direct fluorescent antibody (DFA) test on fresh brain tissue — the gold standard; targets cerebellum, brainstem (medulla oblongata), and hippocampus; highly sensitive and specific [3][4]
• ·Direct rapid immunohistochemistry test (DRIT) — comparable sensitivity to DFA; can be performed on formalin-fixed tissue
• ·RT-PCR — used for variant typing and molecular epidemiology [1][4]
• ·Histopathology — identification of Negri bodies in neurons (H&E stain); less sensitive than DFA but diagnostically meaningful when found
• ·Virus isolation — mouse inoculation or cell culture; primarily a reference laboratory technique

Laboratory and clinical indicators: Laboratory findings in clinical rabies are generally non-specific and are not diagnostic, but may be assessed to rule out other causes of encephalitis:

• ·CBC: May show a mild stress leukogram (neutrophilia with lymphopenia) reflecting systemic stress; no pathognomonic pattern
• ·Serum chemistry: Generally unremarkable in early disease; terminally ill cats may show elevated BUN/CREA due to dehydration and reduced renal perfusion, and elevated ALT as a non-specific stress finding
• ·CSF: Mononuclear pleocytosis (elevated white cell count) with mildly elevated protein — consistent with viral encephalitis but not specific for rabies
• ·Electroencephalography (EEG): Diffuse abnormalities may be detected but are not routinely performed or specific

Differential diagnoses to consider:

• ·Feline infectious peritonitis (neurological form)
• ·Pseudorabies (Aujeszky's disease — causes intense pruritus)
• ·Feline immunodeficiency virus (FIV) encephalopathy
• ·Bacterial meningoencephalitis
• ·Thiamine deficiency (polioencephalomalacea)
• ·Toxoplasmosis
• ·Intoxications (heavy metals, organophosphates)
• ·Intracranial neoplasia

Important public health note: Any cat suspected of having rabies must be handled with strict personal protective equipment (PPE). Euthanasia and brain submission for DFA testing is the standard public health protocol; this is mandatory in most jurisdictions [3][4].

There is no effective treatment for rabies once clinical signs have developed in cats. Rabies encephalitis is considered virtually 100% fatal after onset of neurological signs [3]. The following points outline the management context:

Clinical management:

• ·Immediate humane euthanasia is the universally recommended course of action once rabies is clinically suspected in a cat showing neurological signs, to prevent animal suffering and eliminate further human/animal exposure risk [3][4]
• ·Attempting heroic supportive care (IV fluids, anticonvulsants, nutritional support) is not appropriate given the invariably fatal outcome and the extreme public health danger posed by a potentially infectious, aggressive animal
• ·There are rare, experimental human survival cases using the "Milwaukee Protocol" (medically induced coma plus antiviral therapy), but this protocol has not been validated in veterinary patients, has an extremely poor success rate even in humans, and is not applicable to clinical feline rabies management

Post-exposure protocols (for exposed humans and animals — not a treatment for the infected cat):

• ·Any person bitten or scratched by a suspected rabid cat must immediately undergo wound cleansing with soap and water and receive post-exposure prophylaxis (PEP) — wound infiltration with rabies immune globulin (RIG) followed by a series of rabies vaccines [3][6]
• ·An unvaccinated cat that has been bitten by a known or suspected rabid animal may, under veterinary and public health authority guidance, be placed under strict quarantine (typically 6 months in the USA for unvaccinated animals) or euthanized, depending on jurisdiction
• ·A currently vaccinated cat that has been potentially exposed should receive a rabies booster vaccine promptly and be observed under veterinary supervision per local regulations [4]

Feline rabies carries a mortality rate of effectively 100% once clinical neurological signs have appeared. There are no documented survivals in cats following the onset of clinical rabies, and this is consistent with the known pathophysiology of lyssavirus encephalitis [3]. The disease follows a relentlessly progressive course from clinical onset to death or euthanasia, typically within 3 to 10 days of the appearance of the first neurological signs [3][4].

Key prognostic facts:

• ·The incubation period (time from exposure/bite to clinical signs) in cats ranges from approximately 2 weeks to several months, rarely longer; shorter incubation periods correlate with bites closer to the CNS (e.g., facial bites) and higher viral inoculum [3]
• ·Cats are noted to spend a disproportionate amount of time in the furious phase of rabies compared to dogs, making them particularly dangerous to humans and other animals during clinical illness [3]
• ·In New York State, over a decade of surveillance confirmed cats as the most commonly rabid domestic species, underscoring the ongoing public health risk even in high-income settings with active vaccination programs [4]
• ·In Colombia, cat-associated human rabies cases have increased in Andean regions, demonstrating lethal downstream consequences when feline infection goes unmanaged [6]
• ·In China, cats account for approximately 5% of human rabies cases, reinforcing the serious zoonotic mortality burden associated with unvaccinated feline populations [5]
• ·Given the 100% case-fatality rate, emphasis must be placed entirely on prevention; there is no treatment phase with any realistic hope of recovery

Prevention of feline rabies rests on three pillars: vaccination, population management, and public education [3][5].

Vaccination (most important intervention):

• ·Inactivated (killed) rabies vaccines are the standard of care in most countries. Licensed feline rabies vaccines (e.g., adjuvanted and non-adjuvanted formulations) are widely available and highly immunogenic in cats
• ·Vaccination schedules typically require a primary dose at 12 weeks of age or older, a booster at 1 year, and then either annual or triennial boosters depending on the vaccine label and jurisdictional requirements [3]
• ·Novel vaccine platforms are under investigation; a recombinant feline herpesvirus-1 (FHV-1) vectored vaccine expressing RABV glycoprotein has been developed and tested in China, providing simultaneous protection against both rabies and FHV-1 infection ("dual protection"), representing a promising strategy to improve vaccine uptake in cat populations where rabies is endemic and FHV-1 is common [5]
• ·In countries with endemic canine/wildlife rabies (e.g., Brazil, Colombia, China), systematic inclusion of cats in mass vaccination campaigns alongside dogs is critical and currently underutilized [1][6][3]
• ·Cats pose a unique vaccination access challenge because a lower proportion of the global cat population is registered, veterinary-visited, or vaccinated compared to dogs [3]

Vaccine safety considerations:

• ·Adjuvanted vaccines administered repeatedly at the same anatomical site have been associated with feline injection-site sarcomas (vaccine-associated sarcomas/FISS); this risk, while real and serious, must be weighed against the invariably fatal outcome of rabies [2]
• ·The VAFSTF (Vaccine-Associated Feline Sarcoma Task Force) recommends administering rabies vaccines in a specific low-limb site (distal right hindlimb) to facilitate surgical excision if a sarcoma develops [2]

Husbandry and population management:

• ·Keeping cats indoors or strictly supervising outdoor access dramatically reduces exposure to wildlife RABV reservoirs (bats, raccoons, foxes, skunks) and unvaccinated stray animals [4]
• ·Stray and feral cat management: Trap-Neuter-Return (TNR) programs combined with rabies vaccination of feral cats can reduce the reservoir potential within free-roaming cat populations [3]
• ·Avoid handling wild animals, especially bats, and minimize situations where cats can encounter wildlife

Public health and regulatory measures:

• ·Mandatory rabies vaccination of cats is enforced in many US states and other jurisdictions; expanding and enforcing these requirements is a key public health tool [4]
• ·Rapid reporting of suspected rabid animals to public health authorities enables timely post-exposure prophylaxis for exposed individuals
• ·Oral wildlife rabies vaccination (OWV) programs targeting raccoons, foxes, and coyotes in North America indirectly reduce the source of RABV spillover into cat populations [4]
• ·Education of cat owners regarding the zoonotic risk of rabies and the life-saving value of routine vaccination is essential, particularly in endemic regions [3][6]